gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · PRCTHealthcareSurgical Instruments

PROCEPT BioRobotics Corporation Common Stock (PRCT)

$21.66+7.39%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$21.66▼ 38.15% in range
Nov 4, 2025Low $16.69 · High $36.10Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

PROCEPT BioRobotics closed at $21.66 on Nov 4, up 7.39%, 40.0% below its 52-week closing high. Volume of 2.8M shares was 2.52× its 20-day average (well above normal).

Split-adjusted performance: +23.7% over one month, -12.7% over six months, -37.2% over one year.

In the quarter ended Jun 30, 2026, revenue was $94.50M, up 19.3% from a year earlier, with a net margin of -28.4%.

Short interest was 7.5M shares at the Oct 15 settlement, up 1.0% from the prior report (14.1% of float, 5.6 days to cover).

Market cap$1.24B57.3M shares
Revenue · quarter$94.5M+19.3% YoY
Diluted EPS$-0.47—
P/E · TTM—P/S 3.7×
Net margin-28.4%Gross 66.0%
Dividend yieldNone
52-week range16.69 – 36.10−40.0% from high
Volume2.8M2.52× 20-day avg
Volatility · 60d60.8%Annualised
Short % of float14.1%5.6 days to cover
Net cash$176.2MCash $227.9M
Next earnings—Not scheduled
Split-adjusted performance
1W +7.2%1M +23.7%3M +8.1%6M −12.7%YTD −31.2%1Y −37.2%3Y −13.0%5Y −48.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum42
Revenue growth76
Net margin38
Value (low P/E)—
Size72

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short7.5M+1.0% vs prior
Days to cover5.6Settled Oct 15
% of float14.1%
Short vol. 10d45.9%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
PRCTPROCEPT BioRobotics$21.66+7.39%−12.7%+19.3%−28.4%—$1.24B
ATECAlphatec Holdings$8.28+10.84%+18.5%+12.6%−2.5%—$1.27BCompare
AORTArtivion$26.45+11.56%−23.8%+11.3%−10.7%—$1.29BCompare
TNDMTandem Diabetes Care$19.05+7.93%+5.7%+5.8%−8.3%—$1.33BCompare
IARTIntegra LifeSciences$14.82+8.73%+5.9%+2.3%3.6%88.6$1.15BCompare
SGPSpyGlass Pharma$34.450.00%+37.5%———$1.15BCompare
IRMDiRadimed$88.58+9.21%+2.7%+14.2%26.9%47.2$1.13BCompare
SIBNSI-BONE$24.95+4.96%+92.1%+15.2%−7.3%—$1.12BCompare
BBNXBeta Bionics$16.95+12.25%+60.4%+30.3%−68.6%—$921.5MCompare

News about PROCEPT BioRobotics

All news →
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research · Oct 28, 2026▲ PositiveImportant Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Planet Fitness, Inc. (NYSE: PLNT); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswire Inc. · Oct 28, 2026▼ NegativeLAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders FoundationGlobeNewswire Inc. · Sep 30, 2026▼ NegativeImportant Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswire Inc. · Sep 24, 2026▼ NegativeDeadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlobeNewswire Inc. · Sep 21, 2026▼ Negative

Quick answers

What does PROCEPT BioRobotics do?
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH.
What is PRCT's market cap?
$1.24B, based on the Nov 4 close of $21.66.
Does PROCEPT BioRobotics pay a dividend?
No regular cash dividend has been paid in the last year.
How much of PRCT is sold short?
7.5M shares, 14.1% of float, as of Oct 15, 2026.
What sector is PRCT in?
Healthcare, in the Surgical Instruments industry.

About PROCEPT BioRobotics

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

HQ: San Jose, CA888 employeesListed Sep 15, 2021procept-biorobotics.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology